EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, SILO Pharma's enterprise value is $-1.10 Mil.
SILO Pharma's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was $0.07 Mil. Therefore, SILO Pharma's EV-to-Revenue for today is -15.31.
The historical rank and industry rank for SILO Pharma's EV-to-Revenue or its related term are showing as below:
SILO'
s EV-to-Revenue Range Over the Past 10 Years
Min: -7060.36 Med: -36.69 Max: 17545.66
Current: -15.31
During the past 13 years, the highest EV-to-Revenue of SILO Pharma was 17545.66. The lowest was -7060.36. And the median was -36.69.
SILO's EV-to-Revenue is ranked better than 97.59% of 995
companies
in the Biotechnology industry
Industry Median: 7.6
vs SILO: -15.31
As of today (2025-06-25), SILO Pharma's stock price is $0.6178.
SILO Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was $0.02. Therefore, SILO Pharma's PS Ratio for today is 34.32.
SILO Pharma EV-to-Revenue Historical Data
The historical data trend for SILO Pharma's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of SILO Pharma's EV-to-Revenue
For the Biotechnology subindustry, SILO Pharma's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SILO Pharma's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, SILO Pharma's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where SILO Pharma's EV-to-Revenue falls into.
SILO Pharma's current Enterprise Value is $-1.10 Mil.
SILO Pharma's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.07 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SILO Pharma's share price for today is $0.6178.
SILO Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SILO Pharma EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of SILO Pharma's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SILO has been successfully added to your 